Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been given an average recommendation of “Hold” by the eighteen ratings firms that are presently covering the firm, Marketbeat Ratings reports. Eleven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $11.26.

TDOC has been the topic of a number of recent analyst reports. Bank of America upped their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Oppenheimer cut their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. The Goldman Sachs Group lowered their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, March 3rd. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC lifted its stake in Teladoc Health by 22.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider’s stock valued at $134,000 after buying an additional 2,662 shares in the last quarter. PKO Investment Management Joint Stock Co acquired a new position in shares of Teladoc Health in the 4th quarter valued at $227,000. Brucke Financial Inc. purchased a new position in Teladoc Health during the fourth quarter worth about $92,000. Vise Technologies Inc. boosted its position in shares of Teladoc Health by 4.9% during the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock worth $274,000 after purchasing an additional 1,405 shares during the period. Finally, PharVision Advisers LLC purchased a new position in shares of Teladoc Health during the fourth quarter worth $301,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Up 2.8 %

Shares of TDOC stock opened at $8.86 on Tuesday. The stock’s fifty day moving average price is $10.54 and its 200 day moving average price is $9.73. Teladoc Health has a 1-year low of $6.76 and a 1-year high of $15.68. The company has a market cap of $1.54 billion, a price-to-earnings ratio of -1.54 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. On average, research analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.